Medical Oncology

Guest Editorial
pp. S01-S02(2)
Authors: Keating M.; Hallek M.

A Personal History of the CAMPATH-1H Antibody
pp. S03-S10(8)
Author: Waldmann H.

Current and Developing Chemotherapy for CLL
pp. S11-S20(10)
Author: Montserrat E.

Clinical Effects of Alemtuzumab (Campath-1H) in B-cell Chronic Lymphocytic Leukemia
pp. S21-S26(6)
Authors: Osterborg A.; Mellstedt H.; Keating M.

Alemtuzumab in T-Cell Malignancies
pp. S27-S32(6)
Authors: Dearden C.E.; Matutes E.; Catovsky D.

Alemtuzumab in Stem Cell Transplantation
pp. S33-S48(16)
Author: Hale G.

Immunological Effects and Safe Administration of Alemtuzumab (MabCampath™) in Advanced B-CLL
pp. S49-S56(8)
Authors: Hillmen P.; Kennedy B.

Future Prospects for Alemtuzumab (MabCampath™)
pp. S57-S64(8)
Authors: Rai K.; Hallek M.